Sanofi gets nod for injectable Polio vaccine
The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a potential shortage in the country.
By ET Bureau | Updated:
French drugmaker Sanofi has said it obtained approval for IMOVAX-Polio, an injectable vaccine, from the Indian authorities.
The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a potential shortage in the country.
Sanofi added it stays dedicated to supporting India's public health programme for polio eradication in alignment with the authorities.
The announcement comes a day after ET reported that the company had ceased production of its ShanIPV vaccines in India, which may lead to a potential shortage in the country.
Sanofi added it stays dedicated to supporting India's public health programme for polio eradication in alignment with the authorities.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
Related Articles
Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75ADVERTISEMENT
